Cargando…
Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
BACKGROUND AND OBJECTIVES: Pulmonary arterial hypertension (PAH) is a life threatening disease characterized by progressive pulmonary arterial occlusion which may ultimately result in death. Currently, the available treatments are diverse, but no therapy alone can reverse the disease process althoug...
Autores principales: | Lee, Dong Seok, Kim, Yung Kyu, Jung, Yong Wook |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025340/ https://www.ncbi.nlm.nih.gov/pubmed/21267389 http://dx.doi.org/10.4070/kcj.2010.40.12.659 |
Ejemplares similares
-
Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022) -
Combination use of sildenafil and simvastatin increases BMPR-II signal transduction in rats with monocrotaline-mediated pulmonary hypertension
por: Kuang, Tuguang, et al.
Publicado: (2011) -
Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial
hypertension
por: YOSHIYUKI, Rieko, et al.
Publicado: (2016) -
Preventive effect of sildenafil on right ventricular function in rats with
monocrotaline-induced pulmonary arterial hypertension
por: Yoshiyuki, Rieko, et al.
Publicado: (2016) -
Protective Effect of Right Ventricular Mitochondrial Damage by Cyclosporine A in Monocrotaline-induced Pulmonary Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2018)